Concord Medical Services Stock Working Capital

CCM Stock

USD 0.58 0.05 7.94%

Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.

	Last Reported	Projected for Next Year
Net Working Capital	-325.3 M	-309 M
Change In Working Capital	120.8 M	126.8 M
Working Capital	0.00	0.00

As of the 18th of April 2024, Change In Working Capital is likely to grow to about 126.8 M, though Net Working Capital is likely to grow to (309 M).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Concord Medical Services Company Working Capital Analysis

Concord Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Concord Medical Working Capital

(361.44 M)

Most of Concord Medical's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Concord Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Working Capital. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.55	0.72	0.57	0.8	0.72	0.73	0.74	0.66	0.75	-0.73	0.47	0.68	-0.08	0.24	-0.31	-0.61	-0.74	0.31	0.38	-0.44	0.72	0.66	0.11	-0.76	-0.35	-0.21
Total Stockholder Equity	-0.55		-0.92	-0.66	-0.8	-0.74	-0.01	-0.92	-0.86	-0.83	0.95	-0.44	-0.22	0.58	0.25	0.79	0.66	0.89	-0.27	-0.42	0.37	-0.92	-0.68	-0.05	0.89	0.58	0.54
Long Term Debt	0.72	-0.92		0.76	0.92	0.78	0.33	0.99	0.93	0.96	-0.97	0.56	0.37	-0.46	-0.11	-0.65	-0.67	-0.94	0.38	0.37	-0.46	1.0	0.71	0.01	-0.91	-0.65	-0.64
Good Will	0.57	-0.66	0.76		0.71	0.6	0.31	0.75	0.81	0.79	-0.79	0.88	0.45	-0.4	-0.03	-0.33	-0.21	-0.66	0.07	0.29	0.01	0.71	0.25	0.04	-0.71	-0.61	-0.71
Total Liab	0.8	-0.8	0.92	0.71		0.9	0.53	0.91	0.84	0.97	-0.88	0.61	0.59	-0.18	0.25	-0.59	-0.74	-0.85	0.38	0.45	-0.48	0.91	0.79	0.04	-0.83	-0.55	-0.66
Intangible Assets	0.72	-0.74	0.78	0.6	0.9		0.46	0.8	0.69	0.79	-0.78	0.44	0.47	-0.13	0.19	-0.57	-0.82	-0.74	0.31	0.45	-0.44	0.77	0.84	0.29	-0.83	-0.3	-0.56
Common Stock	0.73	-0.01	0.33	0.31	0.53	0.46		0.34	0.25	0.44	-0.28	0.24	0.63	0.3	0.47	0.21	-0.38	-0.34	0.19	0.14	-0.38	0.33	0.42	0.02	-0.3	-0.15	-0.16
Property Plant Equipment	0.74	-0.92	0.99	0.75	0.91	0.8	0.34		0.91	0.95	-0.97	0.52	0.33	-0.49	-0.14	-0.66	-0.7	-0.94	0.37	0.36	-0.47	1.0	0.73	0.02	-0.93	-0.64	-0.61
Current Deferred Revenue	0.66	-0.86	0.93	0.81	0.84	0.69	0.25	0.91		0.88	-0.93	0.65	0.4	-0.39	-0.15	-0.59	-0.5	-0.86	0.2	0.47	-0.27	0.92	0.54	0.17	-0.85	-0.51	-0.65
Net Debt	0.75	-0.83	0.96	0.79	0.97	0.79	0.44	0.95	0.88		-0.92	0.68	0.51	-0.34	0.15	-0.6	-0.64	-0.87	0.38	0.37	-0.41	0.94	0.69	-0.09	-0.82	-0.7	-0.69
Retained Earnings	-0.73	0.95	-0.97	-0.79	-0.88	-0.78	-0.28	-0.97	-0.93	-0.92		-0.57	-0.39	0.51	0.15	0.66	0.65	0.94	-0.29	-0.43	0.38	-0.96	-0.67	-0.04	0.93	0.63	0.55
Accounts Payable	0.47	-0.44	0.56	0.88	0.61	0.44	0.24	0.52	0.65	0.68	-0.57		0.57	-0.12	0.3	-0.24	-0.02	-0.42	0.04	0.25	0.16	0.49	0.07	-0.04	-0.45	-0.54	-0.65
Net Receivables	0.68	-0.22	0.37	0.45	0.59	0.47	0.63	0.33	0.4	0.51	-0.39	0.57		0.42	0.68	0.03	-0.23	-0.38	0.07	0.42	-0.18	0.33	0.33	-0.03	-0.31	-0.25	-0.23
Total Current Assets	-0.08	0.58	-0.46	-0.4	-0.18	-0.13	0.3	-0.49	-0.39	-0.34	0.51	-0.12	0.42		0.67	0.54	0.22	0.4	-0.1	-0.12	-0.12	-0.48	-0.17	0.25	0.47	0.53	0.19
Short Term Debt	0.24	0.25	-0.11	-0.03	0.25	0.19	0.47	-0.14	-0.15	0.15	0.15	0.3	0.68	0.67		0.12	-0.1	0.17	0.16	0.14	-0.04	-0.14	0.17	-0.21	0.23	-0.03	-0.06
Short Term Investments	-0.31	0.79	-0.65	-0.33	-0.59	-0.57	0.21	-0.66	-0.59	-0.6	0.66	-0.24	0.03	0.54	0.12		0.66	0.57	-0.33	-0.51	0.15	-0.66	-0.65	0.05	0.61	0.38	0.34
Treasury Stock	-0.61	0.66	-0.67	-0.21	-0.74	-0.82	-0.38	-0.7	-0.5	-0.64	0.65	-0.02	-0.23	0.22	-0.1	0.66		0.64	-0.43	-0.48	0.48	-0.7	-0.98	-0.08	0.66	0.24	0.23
Net Tangible Assets	-0.74	0.89	-0.94	-0.66	-0.85	-0.74	-0.34	-0.94	-0.86	-0.87	0.94	-0.42	-0.38	0.4	0.17	0.57	0.64		-0.2	-0.33	0.57	-0.94	-0.67	-0.05	0.95	0.59	0.48
Deferred Long Term Liab	0.31	-0.27	0.38	0.07	0.38	0.31	0.19	0.37	0.2	0.38	-0.29	0.04	0.07	-0.1	0.16	-0.33	-0.43	-0.2		-0.14	-0.47	0.4	0.53	-0.19	-0.19	-0.31	-0.11
Long Term Investments	0.38	-0.42	0.37	0.29	0.45	0.45	0.14	0.36	0.47	0.37	-0.43	0.25	0.42	-0.12	0.14	-0.51	-0.48	-0.33	-0.14		0.22	0.36	0.46	0.0	-0.37	-0.07	-0.17
Short Long Term Debt	-0.44	0.37	-0.46	0.01	-0.48	-0.44	-0.38	-0.47	-0.27	-0.41	0.38	0.16	-0.18	-0.12	-0.04	0.15	0.48	0.57	-0.47	0.22		-0.49	-0.56	-0.17	0.44	0.13	0.17
Long Term Debt Total	0.72	-0.92	1.0	0.71	0.91	0.77	0.33	1.0	0.92	0.94	-0.96	0.49	0.33	-0.48	-0.14	-0.66	-0.7	-0.94	0.4	0.36	-0.49		0.74	0.02	-0.91	-0.63	-0.6
Capital Surpluse	0.66	-0.68	0.71	0.25	0.79	0.84	0.42	0.73	0.54	0.69	-0.67	0.07	0.33	-0.17	0.17	-0.65	-0.98	-0.67	0.53	0.46	-0.56	0.74		0.05	-0.68	-0.3	-0.28
Cash And Equivalents	0.11	-0.05	0.01	0.04	0.04	0.29	0.02	0.02	0.17	-0.09	-0.04	-0.04	-0.03	0.25	-0.21	0.05	-0.08	-0.05	-0.19	0.0	-0.17	0.02	0.05		-0.2	0.68	-0.08
Net Invested Capital	-0.76	0.89	-0.91	-0.71	-0.83	-0.83	-0.3	-0.93	-0.85	-0.82	0.93	-0.45	-0.31	0.47	0.23	0.61	0.66	0.95	-0.19	-0.37	0.44	-0.91	-0.68	-0.2		0.49	0.49
Net Working Capital	-0.35	0.58	-0.65	-0.61	-0.55	-0.3	-0.15	-0.64	-0.51	-0.7	0.63	-0.54	-0.25	0.53	-0.03	0.38	0.24	0.59	-0.31	-0.07	0.13	-0.63	-0.3	0.68	0.49		0.46
Capital Stock	-0.21	0.54	-0.64	-0.71	-0.66	-0.56	-0.16	-0.61	-0.65	-0.69	0.55	-0.65	-0.23	0.19	-0.06	0.34	0.23	0.48	-0.11	-0.17	0.17	-0.6	-0.28	-0.08	0.49	0.46

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Concord Medical

Working Capital Over Time

Concord Capital Surpluse

Capital Surpluse

1.76 Billion

At this time, Concord Medical's Capital Surpluse is very stable compared to the past year.

In accordance with the company's disclosures, Concord Medical Services has a Working Capital of (361.44 Million). This is 184.91% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is 124.45% higher than that of the company.

Concord Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.

Concord Medical is currently under evaluation in working capital category among related companies.

Concord Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	806.0M	781.1M	556.7M	494.1M	568.2M	539.8M
Enterprise Value	2.6B	2.8B	3.1B	3.6B	3.2B	1.7B

Concord Fundamentals

	Return On Equity	-0.31
	Return On Asset	-0.0498
	Profit Margin	(0.76) %
	Operating Margin	(0.75) %
	Current Valuation	7.06 B
	Shares Outstanding	43.42 M
	Shares Owned By Insiders	17.99 %
	Shares Owned By Institutions	0.10 %
	Number Of Shares Shorted	14.54 K
	Price To Earning	(3.90) X
	Price To Book	3.00 X
	Price To Sales	0.04 X
	Revenue	472.08 M
	Gross Profit	(152.41 M)
	EBITDA	(581.17 M)
	Net Income	(768.99 M)
	Cash And Equivalents	157.39 M
	Cash Per Share	1.72 X
	Total Debt	3.24 B
	Debt To Equity	1.25 %
	Current Ratio	0.71 X
	Book Value Per Share	(42.96) X
	Cash Flow From Operations	(216.69 M)
	Short Ratio	0.64 X
	Earnings Per Share	(1.48) X
	Target Price	1.2
	Number Of Employees	918
	Beta	-0.17
	Market Capitalization	27.49 M
	Total Asset	6 B
	Retained Earnings	(3.77 B)
	Working Capital	(361.44 M)
	Current Asset	1.51 B
	Current Liabilities	1.51 B
	Net Asset	6 B

About Concord Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Concord Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Concord Stock

0.63

EMBC

Embecta Corp Financial Report 10th of May 2024

Pair Corr

Moving against Concord Stock

0.87	ELMD	Electromed	Pair Corr
0.83	HIMS	Hims Hers Health Financial Report 13th of May 2024	Pair Corr
0.8	ALC	Alcon AG Financial Report 14th of May 2024	Pair Corr
0.79	BAX	Baxter International Financial Report 25th of April 2024	Pair Corr
0.73	EOLS	Evolus Inc Financial Report 14th of May 2024	Pair Corr

The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.

The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.

	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Global Correlations Find global opportunities by holding instruments from different markets
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.48)

Revenue Per Share

14.017

Quarterly Revenue Growth

0.972

Return On Assets

(0.05)

Return On Equity

(0.31)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Medical Services Stock Working Capital

Concord Medical Services Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Concord Medical Working Capital

Concord Working Capital Driver Correlations

Concord Capital Surpluse

Capital Surpluse

1.76 Billion

Concord Working Capital Peer Comparison

Concord Medical Current Valuation Drivers

Concord Fundamentals

About Concord Medical Fundamental Analysis

Pair Trading with Concord Medical

Moving together with Concord Stock

Moving against Concord Stock

Complementary Tools for Concord Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY